このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Modality-Specific Heart Rate Differences at Ventilatory Thresholds During Unified Ramp Testing

2026年7月17日 更新者:Tung-Chou Li、Cathay General Hospital

Evaluation of Heart Rate and Ventilatory Threshold Agreement Between Cycling and Running Under Strictly Standardized Ramp Conditions

The purpose of this study was to investigate the heart rate bias between cycling and treadmill exercise at ventilatory thresholds. This was a randomized crossover trial involving 23 healthy participants. Each participant performed both cycling and treadmill exercise tests in a randomized order. The primary outcome was to determine the difference in heart rate response at the first and second ventilatory thresholds between the two exercise modalities. We hypothesized that there is a fixed bias in heart rate response, which may have implications for exercise prescription in clinical and rehabilitation settings.

調査の概要

詳細な説明

Participants Twenty-three healthy adults (12 men, 11 women; age 30.8 ± 5.6 years; BMI 21.8 ± 2.6 kg/m²) were recruited via institutional advertisements at a university hospital. Inclusion criteria were: age ≥ 20 years, familiarity with cycling and treadmill exercise, and a negative Physical Activity Readiness Questionnaire response. Exclusion criteria were: history of cardiovascular, pulmonary, or metabolic disease; musculoskeletal injuries limiting exercise range of motion; or medications affecting heart rate or ventilation. Participants fasted for 3 hours, abstained from vigorous exercise, alcohol, and caffeine for 24 hours prior to testing, and provided written informed consent. Data collection was conducted between February 2024 and November 2024. The protocol was approved by the Institutional Review Board of National Taiwan University Hospital (IRB Registration: 202311036RIND).

Experimental Design A randomized crossover design was employed. Participants completed two symptom-limited CPET sessions on a cycle ergometer (VIAsprint, Ergoline, Germany) and motorized treadmill (Ergosprint, Ergoline, Germany), separated by 7-14 days and conducted at the same time of day (±2 hours) to control for circadian effects. The randomized order minimized potential order effects and ensured that fatigue from the first test did not systematically bias results.

Cardiopulmonary Exercise Testing Protocol Gas Exchange Measurement and Safety Monitoring Breath-by-breath gas exchange was measured using a metabolic cart (Vmax Encore, CareFusion, USA), calibrated before each test with standard gases and a 3-L calibration syringe. Heart rate was monitored continuously via 12-lead electrocardiography (Cardiosoft, GE Healthcare, USA), providing greater temporal resolution than telemetric methods. Blood pressure was measured at rest and every 2 minutes during exercise to monitor safety and detect cardiovascular abnormalities.

Unified Ramp Protocol The central innovation was implementing a unified ramp protocol on both modalities to eliminate kinetic confounding.

Cycle Ergometer: Following a 3-minute unloaded warm-up (0 W), continuous ramp increases began at 20 W·min-¹ (men) or 15 W·min-¹ (women), targeting an 8-12 minute test duration to optimize threshold identification within a physiologically relevant window.

Treadmill: Using the Porszász algorithm, simultaneous adjustments to speed and grade produced metabolically equivalent work rate increases (20 or 15 W·min-¹), matched to cycling. Warm-up consisted of 3 minutes at 3-4 km/h, 0% grade. The Porszász protocol mathematically calculates the non-linear combination of speed and grade increases needed to produce a linear rise in metabolic demand, ensuring identical oxygen uptake kinetic demands despite different biomechanical constraints.

Maximal Effort Verification Participants exercised to volitional exhaustion or until safety criteria were met. Maximal effort was confirmed by meeting ≥2 of the following criteria: respiratory exchange ratio (RER) ≥ 1.10; heart rate within 10 bpm of age-predicted maximum (220 - age); rating of perceived exertion (RPE) ≥ 17 on the Borg 6-20 scale; or VO₂ plateau (≤150 mL·min-¹ increase despite increasing workload).

Threshold Determination Breath-by-breath gas exchange data were binned into 5-second moving averages to attenuate noise while preserving dynamic resolution at the threshold transition point. VT1 and VT2 were identified independently by two blinded, experienced raters using consensus criteria (V-slope method, ventilatory equivalents, end-tidal gas tensions). Blinding was maintained by removing all identifiers before threshold determination. Disagreements (2 cases) were adjudicated by a third blinded expert. Inter-rater reliability was excellent (ICC = 0.94 for VT1; ICC = 0.96 for VT2). Variables were extracted as 30-second averages centered on the identified threshold time point to ensure stability.

Statistical Analysis Primary and Secondary Outcomes Primary outcome: heart rate difference at VT1 and VT2 between modalities. Secondary outcomes: absolute and relative VO₂, EqO₂, EqCO₂, and O₂ pulse.

Data Analysis Methods Data normality was assessed using the Shapiro-Wilk test. Paired t-tests compared variables between modalities, with two-tailed significance testing at α = 0.05. Intraclass correlation coefficients (ICC; two-way mixed-effects, absolute agreement) assessed measurement reliability. Measurement error was quantified using the coefficient of variation (CV = SD of differences/mean), which normalizes variability to enable comparison across variables with different scales.

Bland-Altman Regression Analysis for Proportional Bias Bland-Altman analysis with linear regression tested for fixed versus proportional bias-the core statistical innovation distinguishing this study. The difference between modalities (Cycling - Treadmill) was regressed against the mean of the two measurements. A non-significant regression slope (p > 0.05) indicated fixed bias, whereas a significant slope (p < 0.05) indicated proportional bias. This approach directly tests whether correction factors should be constant across participants or adjusted based on individual physiological capacity.

All statistical analyses were performed using SPSS Statistics Version 20 (IBM Corp., Armonk, NY) for ICC and t-tests, and GraphPad Prism Version 10 (GraphPad Software, San Diego, CA) for Bland-Altman plots.

研究の種類

介入

入学 (実際)

23

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Taipei City
      • Taipei、Taipei City、台湾、10630
        • Cathay General Hospitla

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

はい

説明

Inclusion Criteria:

  1. Age ≥ 20 years.
  2. Familiarity with both cycling and treadmill exercise.
  3. Negative response on the Physical Activity Readiness Questionnaire (PAR-Q).

Exclusion Criteria:

  1. History of cardiovascular, pulmonary, or metabolic disease.
  2. Musculoskeletal injuries limiting exercise range of motion.
  3. Use of medications known to affect heart rate or ventilation.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:基礎科学
  • 割り当て:ランダム化
  • 介入モデル:クロスオーバー割り当て
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Cycling-First Sequence
Participants in this arm are randomized to perform the continuous ramp cardiopulmonary exercise testing (CPET) on a cycle ergometer first. After a washout period of 7 to 14 days, they cross over to perform the standardized treadmill ramp testing.
Following a 3-minute unloaded warm-up (0 W), continuous ramp increases began at 20 W/min for men or 15 W/min for women, targeting an 8-12 minute test duration to volitional exhaustion.
Standardized ramp testing utilizing the Porszász algorithm. Simultaneous adjustments to speed and grade mathematically produce a linear rise in metabolic demand (matched to 20 or 15 W/min based on sex), ensuring identical oxygen uptake kinetic demands to the cycling protocol.
実験的:Treadmill-First Sequence
Participants in this arm are randomized to perform the standardized treadmill ramp cardiopulmonary exercise testing (CPET) using the Porszász algorithm first. After a washout period of 7 to 14 days, they cross over to perform the cycle ergometer ramp testing.
Following a 3-minute unloaded warm-up (0 W), continuous ramp increases began at 20 W/min for men or 15 W/min for women, targeting an 8-12 minute test duration to volitional exhaustion.
Standardized ramp testing utilizing the Porszász algorithm. Simultaneous adjustments to speed and grade mathematically produce a linear rise in metabolic demand (matched to 20 or 15 W/min based on sex), ensuring identical oxygen uptake kinetic demands to the cycling protocol.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Modality-Specific Heart Rate Differences at Ventilatory Thresholds (VT1 and VT2)
時間枠:Identified during each 8 to 12-minute cardiopulmonary exercise test session (Sessions separated by 7 to 14 days).
The absolute difference in heart rate (measured in beats per minute, bpm) recorded at the first ventilatory threshold (VT1) and second ventilatory threshold (VT2) between cycle ergometry and treadmill running.
Identified during each 8 to 12-minute cardiopulmonary exercise test session (Sessions separated by 7 to 14 days).

二次結果の測定

結果測定
メジャーの説明
時間枠
Oxygen Consumption (VO2) at Thresholds and Peak
時間枠:Extracted as 30-second averages centered on the threshold time points and peak during each exercise test session.
Absolute and relative oxygen consumption (mL/kg/min) at VT1, VT2, and peak exercise.
Extracted as 30-second averages centered on the threshold time points and peak during each exercise test session.
Ventilatory Equivalent for Carbon Dioxide (EqCO2)
時間枠:immediately after exercise test
VE/VCO2 ratio at VT1 and VT2 to assess cross-modal reliability.
immediately after exercise test
Oxygen Pulse (O2 pulse)
時間枠:immediately after exercise test
Calculated as VO2 divided by heart rate (mL/beat) at VT1 and VT2 to evaluate stroke volume and tissue extraction markers across modalities.
immediately after exercise test

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2024年2月1日

一次修了 (実際)

2024年11月30日

研究の完了 (実際)

2024年11月30日

試験登録日

最初に提出

2026年7月14日

QC基準を満たした最初の提出物

2026年7月17日

最初の投稿 (実際)

2026年7月22日

学習記録の更新

投稿された最後の更新 (実際)

2026年7月22日

QC基準を満たした最後の更新が送信されました

2026年7月17日

最終確認日

2026年7月1日

詳しくは

本研究に関する用語

追加の関連 MeSH 用語

その他の研究ID番号

  • 202311036RIND

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

The de-identified individual participant data that underlie the results reported in this article will be available to other researchers who provide a methodologically sound proposal. Proposals may be submitted to the corresponding author twdoggy@yahoo.com.tw for review. Data access will be granted upon signature of a data access agreement and ethical approval.

IPD 共有時間枠

The data and supporting documents will be available immediately following the publication of the article and will remain available for 5 years after publication.

IPD 共有アクセス基準

Researchers interested in accessing the IPD or supporting documentation must submit a methodologically sound research proposal to the corresponding author for review. The proposal should clearly state the research question and the intended use of the data. Access to the de-identified data will be granted to researchers who meet the criteria after signing a data access agreement and demonstrating institutional ethical approval. Requests will be evaluated on a case-by-case basis to ensure participant privacy and data security.

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する